Yan-Ping Shi, Zhang-Lei Pan, Jing Zhang, Ling-Yu Xue, Ming-Qiang Li
{"title":"Gut dysbiosis, low-grade inflammation, and renal impairment severity in elderly diabetic nephropathy.","authors":"Yan-Ping Shi, Zhang-Lei Pan, Jing Zhang, Ling-Yu Xue, Ming-Qiang Li","doi":"10.4239/wjd.v16.i8.108245","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The specific mechanism of diabetic nephropathy (DN) has not been fully elucidated, and more and more evidence shows that the development of DN is related to intestinal flora imbalance and micro-inflammatory state process, and this mechanism urgently needs to be further clarified by relevant research.</p><p><strong>Aim: </strong>To investigate the correlation between intestinal microbiota dysbiosis, low-grade inflammatory status, renal function impairment, and disease severity in older patients with DN, in order to provide a basis for the prevention and therapeutic intervention of DN.</p><p><strong>Methods: </strong>We enrolled 167 older patients with DN, diagnosed in the Department of Nephrology between June 2020 and June 2023. Eighty-five patients with type 2 diabetes mellitus (without DN) were enrolled to serve as the control group. A one-year follow-up observation was conducted. We compared the differences in gut microbiota composition, levels of inflammatory markers, and renal function indicators between the two groups, and the characteristics of gut microbiota and the changing patterns of inflammatory markers across different stages of disease progression.</p><p><strong>Results: </strong>In the DN group, the Chao, Ace, and Shannon indices were significantly lower, while the Simpson index was significantly higher than the control group. The relative abundances of <i>Bacteroides</i> and <i>Bifidobacterium</i> were significantly lower, whereas the relative abundances of <i>Clostridium, Butyricimonas, Klebsiella, Enterococcus, Veillonella</i>, and <i>Megamonas</i> were significantly higher than those in the control group (<i>P</i> < 0.05). Estimated glomerular filtration rate was positively correlated with the Chao, Ace, and Shannon diversity indices of the gut microbiota, as well as with the relative abundances of <i>Bacteroides, Bifidobacterium</i>, and <i>Akkermansia</i>, and was negatively correlated with the relative abundances of <i>Clostridium, Klebsiella,</i> and <i>Enterococcus</i> (<i>P</i> < 0.05). Logistic regression analysis indicated that lower Chao, Ace, and Shannon indices and higher Simpson index were associated with an increased risk of developing DN. After one year of follow-up, patients in the progression group exhibited a significantly greater decrease in Chao, Ace, and Shannon indices and a greater increase in Simpson index than the stable group. The reduction in the relative abundances of <i>Bacteroides, Clostridium, Bifidobacterium,</i> and <i>Butyricimonas</i>, as well as the increase in <i>Klebsiella, Enterococcus, Veillonella,</i> and <i>Megamona</i>s, were significantly more pronounced in the progression group than in the stable group (<i>P</i> < 0.05). Regression analysis indicated that greater declines in Chao, Ace, and Shannon indices and <i>Bacteroides</i> relative abundance, along with greater increases in Simpson index and <i>Enterococcus</i> relative abundance, were associated with a more rapid decline in renal function.</p><p><strong>Conclusion: </strong>The onset and progression of DN in older patients with diabetes are closely associated with gut microbiota composition. The more severe the dysbiosis, the lower the abundance of beneficial bacteria and the higher the abundance of harmful bacteria, leading to an increased risk of both DN occurrence and disease progression.</p>","PeriodicalId":48607,"journal":{"name":"World Journal of Diabetes","volume":"16 8","pages":"108245"},"PeriodicalIF":4.6000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362445/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4239/wjd.v16.i8.108245","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The specific mechanism of diabetic nephropathy (DN) has not been fully elucidated, and more and more evidence shows that the development of DN is related to intestinal flora imbalance and micro-inflammatory state process, and this mechanism urgently needs to be further clarified by relevant research.
Aim: To investigate the correlation between intestinal microbiota dysbiosis, low-grade inflammatory status, renal function impairment, and disease severity in older patients with DN, in order to provide a basis for the prevention and therapeutic intervention of DN.
Methods: We enrolled 167 older patients with DN, diagnosed in the Department of Nephrology between June 2020 and June 2023. Eighty-five patients with type 2 diabetes mellitus (without DN) were enrolled to serve as the control group. A one-year follow-up observation was conducted. We compared the differences in gut microbiota composition, levels of inflammatory markers, and renal function indicators between the two groups, and the characteristics of gut microbiota and the changing patterns of inflammatory markers across different stages of disease progression.
Results: In the DN group, the Chao, Ace, and Shannon indices were significantly lower, while the Simpson index was significantly higher than the control group. The relative abundances of Bacteroides and Bifidobacterium were significantly lower, whereas the relative abundances of Clostridium, Butyricimonas, Klebsiella, Enterococcus, Veillonella, and Megamonas were significantly higher than those in the control group (P < 0.05). Estimated glomerular filtration rate was positively correlated with the Chao, Ace, and Shannon diversity indices of the gut microbiota, as well as with the relative abundances of Bacteroides, Bifidobacterium, and Akkermansia, and was negatively correlated with the relative abundances of Clostridium, Klebsiella, and Enterococcus (P < 0.05). Logistic regression analysis indicated that lower Chao, Ace, and Shannon indices and higher Simpson index were associated with an increased risk of developing DN. After one year of follow-up, patients in the progression group exhibited a significantly greater decrease in Chao, Ace, and Shannon indices and a greater increase in Simpson index than the stable group. The reduction in the relative abundances of Bacteroides, Clostridium, Bifidobacterium, and Butyricimonas, as well as the increase in Klebsiella, Enterococcus, Veillonella, and Megamonas, were significantly more pronounced in the progression group than in the stable group (P < 0.05). Regression analysis indicated that greater declines in Chao, Ace, and Shannon indices and Bacteroides relative abundance, along with greater increases in Simpson index and Enterococcus relative abundance, were associated with a more rapid decline in renal function.
Conclusion: The onset and progression of DN in older patients with diabetes are closely associated with gut microbiota composition. The more severe the dysbiosis, the lower the abundance of beneficial bacteria and the higher the abundance of harmful bacteria, leading to an increased risk of both DN occurrence and disease progression.
期刊介绍:
The WJD is a high-quality, peer reviewed, open-access journal. The primary task of WJD is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of diabetes. In order to promote productive academic communication, the peer review process for the WJD is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJD are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in diabetes. Scope: Diabetes Complications, Experimental Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes, Gestational, Diabetic Angiopathies, Diabetic Cardiomyopathies, Diabetic Coma, Diabetic Ketoacidosis, Diabetic Nephropathies, Diabetic Neuropathies, Donohue Syndrome, Fetal Macrosomia, and Prediabetic State.